Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition characterized by altered liver function due to fatty accumulation, which can lead to liver inflammation and, in advanced stages, liver carcinoma. MASLD is closely linked to several metabolic alterations, such as obesity...

Full description

Saved in:
Bibliographic Details
Main Authors: Francisco Aguirre, Mayalen Valero-Breton, Daniel Cabrera, Luis Peñailillo, María Carolina Otero, Claudia Fredes, Claudio Cabello-Verrugio
Format: Article
Language:English
Published: PAGEPress Publications 2025-07-01
Series:European Journal of Translational Myology
Subjects:
Online Access:https://www.pagepressjournals.org/bam/article/view/13365
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850061681723441152
author Francisco Aguirre
Mayalen Valero-Breton
Daniel Cabrera
Luis Peñailillo
María Carolina Otero
Claudia Fredes
Claudio Cabello-Verrugio
author_facet Francisco Aguirre
Mayalen Valero-Breton
Daniel Cabrera
Luis Peñailillo
María Carolina Otero
Claudia Fredes
Claudio Cabello-Verrugio
author_sort Francisco Aguirre
collection DOAJ
description Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition characterized by altered liver function due to fatty accumulation, which can lead to liver inflammation and, in advanced stages, liver carcinoma. MASLD is closely linked to several metabolic alterations, such as obesity and insulin resistance, which directly affect skeletal muscles and contribute to the development of sarcopenia. Sarcopenia is the loss of muscle mass and strength, leading to decreased physical performance in severe stages. Skeletal muscles secrete molecules known as myokines under various conditions, such as exercise or diseases like MASLD. These myokines modulate communication between the skeletal muscle and other tissues. These myokines regulate muscle mass and, in pathological conditions, contribute to the development of sarcopenia. Emerging evidence highlights the crucial role of myokines in regulating skeletal muscle metabolism and function in MASLD. Myokines influence muscle metabolism, inflammation, and insulin sensitivity, offering potential therapeutic targets for managing muscle atrophy and sarcopenia in the context of MASLD. Understanding the interaction between myokines and skeletal muscle may lead to novel interventions to mitigate MASLD progression and sarcopenia. This review examines the mechanisms by which myokines regulate skeletal muscle metabolism and function in the context of MASLD.
format Article
id doaj-art-ab0b5f46922344d68fe052d6d467a15a
institution DOAJ
issn 2037-7452
2037-7460
language English
publishDate 2025-07-01
publisher PAGEPress Publications
record_format Article
series European Journal of Translational Myology
spelling doaj-art-ab0b5f46922344d68fe052d6d467a15a2025-08-20T02:50:08ZengPAGEPress PublicationsEuropean Journal of Translational Myology2037-74522037-74602025-07-0110.4081/ejtm.2025.13365Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative reviewFrancisco Aguirre0Mayalen Valero-Breton1Daniel Cabrera2Luis Peñailillo3María Carolina Otero4Claudia Fredes5Claudio Cabello-Verrugio6Center for Research on Pandemic Resilience, Faculty of Life Sciences and Institute of Public Health, Universidad Andres Bello, Santiago, Chile; Laboratory of Muscle Pathology, Fragility and Aging, Department of Biological Sciences, Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Faculty of Life Sciences, Universidad Andres Bello, SantiagoCenter for Research on Pandemic Resilience, Faculty of Life Sciences and Institute of Public Health, Universidad Andres Bello, Santiago, Chile; Laboratory of Muscle Pathology, Fragility and Aging, Department of Biological Sciences, Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Faculty of Life Sciences, Universidad Andres Bello, SantiagoCenter for Biomedical Research and Innovation (CiiB), Faculty of Medicine, Universidad de los Andes, Santiago, Chile; Facultad de Ciencias de la Salud, Escuela de Kinesiología, Universidad Bernardo O Higgins, SantiagoExercise and Rehabilitation Sciences Institute, School of Physical Therapy, Faculty of Rehabilitation Sciences, Universidad Andrés Bello, SantiagoEscuela de Química y Farmacia, Facultad de Medicina, Universidad Andres Bello, SantiagoExercise and Rehabilitation Sciences Institute, Postgraduate, Faculty of Rehabilitation Sciences, Universidad Andres Bello, SantiagoCenter for Research on Pandemic Resilience, Faculty of Life Sciences and Institute of Public Health, Universidad Andres Bello, Santiago, Chile; Laboratory of Muscle Pathology, Fragility and Aging, Department of Biological Sciences, Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Faculty of Life Sciences, Universidad Andres Bello, SantiagoMetabolic dysfunction-associated steatotic liver disease (MASLD) is a condition characterized by altered liver function due to fatty accumulation, which can lead to liver inflammation and, in advanced stages, liver carcinoma. MASLD is closely linked to several metabolic alterations, such as obesity and insulin resistance, which directly affect skeletal muscles and contribute to the development of sarcopenia. Sarcopenia is the loss of muscle mass and strength, leading to decreased physical performance in severe stages. Skeletal muscles secrete molecules known as myokines under various conditions, such as exercise or diseases like MASLD. These myokines modulate communication between the skeletal muscle and other tissues. These myokines regulate muscle mass and, in pathological conditions, contribute to the development of sarcopenia. Emerging evidence highlights the crucial role of myokines in regulating skeletal muscle metabolism and function in MASLD. Myokines influence muscle metabolism, inflammation, and insulin sensitivity, offering potential therapeutic targets for managing muscle atrophy and sarcopenia in the context of MASLD. Understanding the interaction between myokines and skeletal muscle may lead to novel interventions to mitigate MASLD progression and sarcopenia. This review examines the mechanisms by which myokines regulate skeletal muscle metabolism and function in the context of MASLD. https://www.pagepressjournals.org/bam/article/view/13365Metabolic dysfunction-associated steatotic liver diseasesarcopeniamyokines
spellingShingle Francisco Aguirre
Mayalen Valero-Breton
Daniel Cabrera
Luis Peñailillo
María Carolina Otero
Claudia Fredes
Claudio Cabello-Verrugio
Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review
European Journal of Translational Myology
Metabolic dysfunction-associated steatotic liver disease
sarcopenia
myokines
title Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review
title_full Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review
title_fullStr Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review
title_full_unstemmed Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review
title_short Impact of myokines on chronic liver diseases: exploring the effects of metabolic dysfunction-associated steatotic liver disease (MASLD) on skeletal muscle. A narrative review
title_sort impact of myokines on chronic liver diseases exploring the effects of metabolic dysfunction associated steatotic liver disease masld on skeletal muscle a narrative review
topic Metabolic dysfunction-associated steatotic liver disease
sarcopenia
myokines
url https://www.pagepressjournals.org/bam/article/view/13365
work_keys_str_mv AT franciscoaguirre impactofmyokinesonchronicliverdiseasesexploringtheeffectsofmetabolicdysfunctionassociatedsteatoticliverdiseasemasldonskeletalmuscleanarrativereview
AT mayalenvalerobreton impactofmyokinesonchronicliverdiseasesexploringtheeffectsofmetabolicdysfunctionassociatedsteatoticliverdiseasemasldonskeletalmuscleanarrativereview
AT danielcabrera impactofmyokinesonchronicliverdiseasesexploringtheeffectsofmetabolicdysfunctionassociatedsteatoticliverdiseasemasldonskeletalmuscleanarrativereview
AT luispenailillo impactofmyokinesonchronicliverdiseasesexploringtheeffectsofmetabolicdysfunctionassociatedsteatoticliverdiseasemasldonskeletalmuscleanarrativereview
AT mariacarolinaotero impactofmyokinesonchronicliverdiseasesexploringtheeffectsofmetabolicdysfunctionassociatedsteatoticliverdiseasemasldonskeletalmuscleanarrativereview
AT claudiafredes impactofmyokinesonchronicliverdiseasesexploringtheeffectsofmetabolicdysfunctionassociatedsteatoticliverdiseasemasldonskeletalmuscleanarrativereview
AT claudiocabelloverrugio impactofmyokinesonchronicliverdiseasesexploringtheeffectsofmetabolicdysfunctionassociatedsteatoticliverdiseasemasldonskeletalmuscleanarrativereview